semaglutide
5 Glp-1 Wins: Heavy Drinking Reduced, Obesity Treatment
In a 2023 trial of 150 adults, tirzepatide reduced heavy-drinking days by 27% while delivering an average 15-kg weight loss. Medical Disclaimer: This article is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional before making health decisions. Obesity Treatment Impact on Heavy